tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Sarepta Therapeutics (SRPT) and Intuitive Surgical (ISRG)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Elevance Health (ELVResearch Report), Sarepta Therapeutics (SRPTResearch Report) and Intuitive Surgical (ISRGResearch Report) with bullish sentiments.

Elevance Health (ELV)

RBC Capital analyst Ben Hendrix reiterated a Buy rating on Elevance Health yesterday and set a price target of $575.00. The company’s shares closed last Thursday at $525.19, close to its 52-week high of $539.11.

According to TipRanks.com, Hendrix is a 3-star analyst with an average return of 1.2% and a 51.3% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Walgreens Boots Alliance, and Brookdale Senior Living.

Elevance Health has an analyst consensus of Strong Buy, with a price target consensus of $591.36, representing a 13.6% upside. In a report issued on April 8, Wells Fargo also maintained a Buy rating on the stock with a $557.00 price target.

See today’s best-performing stocks on TipRanks >>

Sarepta Therapeutics (SRPT)

RBC Capital analyst Brian Abrahams maintained a Buy rating on Sarepta Therapeutics today and set a price target of $154.00. The company’s shares closed last Thursday at $116.55.

According to TipRanks.com, Abrahams is a 4-star analyst with an average return of 6.5% and a 46.6% success rate. Abrahams covers the Healthcare sector, focusing on stocks such as Neumora Therapeutics, Inc., Intra-Cellular Therapies, and Karyopharm Therapeutics.

Sarepta Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $169.47, implying a 44.2% upside from current levels. In a report issued on April 4, Citi also maintained a Buy rating on the stock with a $172.00 price target.

Intuitive Surgical (ISRG)

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Intuitive Surgical yesterday and set a price target of $432.00. The company’s shares closed last Thursday at $372.63.

According to TipRanks.com, Chadha is a 1-star analyst with an average return of -1.4% and a 37.0% success rate. Chadha covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $421.88 average price target, a 13.2% upside from current levels. In a report issued on April 3, Citi also maintained a Buy rating on the stock with a $462.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ELV:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles